Role of HLA-B27 in spondyloarthropathies

Current Topics in Microbiology and Immunology

Volumn 206, Issue , 1996, Pages 84-100

  Khare, S D ^a   Luthra, H S ^a   David, C S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BETA 2 MICROGLOBULIN; COLLAGEN; HLA B27 ANTIGEN;

ANIMAL MODEL; ANKYLOSING SPONDYLITIS; ARTHRITIS; BACTERIAL INFECTION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPONDYLARTHRITIS; TRANSGENIC ANIMAL; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS; AUTOANTIGENS; BACTERIA; COLLAGEN; HLA-B27 ANTIGEN; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR MIMICRY; SPONDYLITIS; SPONDYLITIS, ANKYLOSING;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS;

EID: 0030065345     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-85208-4_6     Document Type: Article

References (77)

1. Abu-Hadid MM, Fuji H, Sood AK (1994) Alternatively spliced MHC class I mRNAs show specific deletion of sequences encoding the extracellular polymorphic domain Int Immunol 6: 323-337
2. Benjamin RJ, Madrigal JA, Parham P (1991) Peptide binding to empty HLA-B27 molecules of viable human cells Nature 351: 74-77
3. Bjorkman PJ, Saper MA, Samraoui B, Bennet WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen HLA-A2. Nature 329: 506-512
4. Breban M, Hammer RE, Richardson JA, Taurog JD (1993) Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 178: 1607-1616
5. Brooks JM, Murrey RJ, Thomas WA, Kurilla MG, Rickinson AB (1993) Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J Exp Med 178. 879-887
6. Cameron FH, Russell PJ, Easter JF, Wakefietd D, March L (1987) Failure of anti-Klebsiella pneumoniae antibodies to cross react with peripheral blood mononuclear cells from patients with ankylosing spondyhtis. Arthritis Rheum 30: 300-305
7. Capps GG, Robinson BE, Lewis KD, Zuniga MC (1993) In vivo dimeric association of class i MHC heavy chains. J Immunol 151: 159-169
8. Chen J-H, Kono DH, Yong Z, Park MS, Oldstone MB, Yu DTU (1987) A Yersinia pseudotuberculosis protein which cross reacts with HLA-B27. J Immunol 139. 3003-3011
9. Colbert RA, Rowland-Jones SL, McMichal AJ, Frelinger JA (1994) Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide to B*2703. Immunity 1: 121-130
10. Collona M, Bresnahan M, Bahram S, Strominger JL, Spices T (1992) Allelic variations of the human putative transporter involved in antigen processing Proc Natl Acad Sci USA 89: 3932-3936
11. Coppin HL, McDevitt HO (1986) Absence of polymorphism between HLA-B27 genomic exon sequences isolated from normal donors and ankylosing spondylitis patients. J Immunol 137: 2168-2172
12. Danliczyk UG, Delovitch TI (1994) β2-microglobulin induces a conformational change in an MHC class I H chain that occurs intracellutarly and is maintained at the cell surface J Immunol 153 3353-3541
13. De los Toyos JR, Menendez P, Sampedro A, Hardisson C (1992) Yersinia enterocolitica 0:3-induced arthritis in mice: microbiological and histopathological information. APMIS 100. 455-464
14. De los Toyos JR, Diaz R, Hardisson C (1993) Protection against the iethal effect and arthritogenic capacity of Yersinia enterocolitica serovar 0:3 for mice. FEMS Microbiol Immunol 76: 289-298
15. Fukazawa T, Hermann E, Edidin M, Juan W, Huang F, Kellner H, Floege J, Farahmandian D, Williams KM, Yu DTU (1994) The effect of β2-microglobulins on the conformation of HLA-B27 detected by antibody and by CTL. J Imrnunol 153: 3543-3550
16. Gao X-M, Woodsworth P, McMichal A (1994) Collagen-specific cytotoxic T lymphocyte responses in patients with ankylosing spondylitis and reactive arthritis Eur J Immunol 24. 1665-1670
17. Gran JT, Husby G (1994) Ankylosing spondylitis prevalence and demography. In: Klippel JH, Dieppe PA (eds) Rheumatology Mosby, London, pp 1-6
18. Granfors K, Jalkanen S, Lindberg AA, Maki-Ikola D, van Essen R, Lahesmaa-Rantala R, Isomaki H, Saario R, Arnold WJ, Toivanen A (1990) Salmonella polysaccharide in synovial cells from patients with reactive arthritis Lancet 335: 685-688
19. Granfors K, Jalkanen S, Toivanen A, Koski J, Lindberg AA (1992) Bacterial polysaccharide in synovial fluid cells in Shigella triggered reactive arthritis J Rheumatol 19: 500
20. Hammer RE, Maika SD, Richardson JA, Tang J-P, Taurog JD (1990) Spontaneous inflammatory disease in transgenic mice expressing HLA-B27 and human p2m an animal model of HLA-B27-associated human disorders Cell 63: 1099-1112
21. Hermann E, Yu DTC (1993) HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and snkylosing spondylitis. Lancet 342. 646-650
22. Hughes RA, Hyder E, Treharne JD, Keat AC (1991) Intra-articular chlamydial antigen and inflammatory arthritis Q J Med 291. 575-588
23. Husby G, Tsuchiya N, Schwimmbeck PL, Keat A, Pahle JA, Oldstone MB, Williams RC Jr (1989) Crossreactive epitope with Klebsiella pneumoniae nitrogenase in articular tissues of HLA-B27+ patients with ankylosing spondylitis Arthritis Rheum 32: 437-445
24. Ivanyi P, Eulderink F, Alphan V, Capkova J, Gaeda K, Heesemann J, Hoebe-Hewryk B, Kievits F, Lokhorst W, Pla M, Weinreick S, Zurcher C (1991) Joint diseases in B27 transgenic mice. In Lipsky PE, Taurog JD (eds) HLA-B274+ spondyloarthropathies. Elsevier, Amsterdam, pp 71-83
25. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC (1991) Identification of self peptides bound to purified HLA-B27. Nature 353. 326-329
26. Kalinke U, Arnold B, Hammerling GJ (1990) Strong xenogeneic HLA response in transgenic mice after introducing an γ3 domain into HLA-B27. Nature 348: 642-644
27. Kellner H, Wen J, Wang J, Raybourne RB, Williams KM, Yu DTU (1994) Senum antibodies from patients with ankylosing spondylitis and Reiter's syndrome are reactive with HLA-B27 cells transfected with the Mycobacterium tuberculosis hsp 40 logene. Infect Immun 62: 284-291
28. Khan MA (1994) Spondyloarthropathies Curr Opin Rheumatol 6: 351-353
29. Kono DH, Ogasawara M, Effors RB, Park MS, Walford RL, Yu DTU (1985) Ye-1 monoclonal antibody that cross reacts with HLA-B27 lymphoblatoid cell lines and an arthritis causing bacteria. Cli Exp Immunol 61 503-508
30. Kool J, Ruseler van Embden JGH, van Lieshout LMC, de Visser H, Gerrits-Boeye MY, van den Berg WG, Hazenberg MP (1991) Induction of arthritis in rats by soluble peptidoglycan-polysaccharide complexes produced by human intestinal flora. Arthritis Rheum 34: 1611-1616
31. Krimpenfort P, Rudenko G, Hochstenbach F, Guessow D, Berns A, Plough H (1987) Crosses of two independently derived transgenic mice demonstrate functional complementation of the genes encoding heavy (HLA-B27) and light (beta 2 microglobulin) chains of HLA class I antigens EMBO J 6: 1673-1676
32. Krishna S, Benaroch P, Pillai S (1992) Tetrameric cell-surface MHC class I molecules. Nature 357: 164-167
33. Lahesmaa R, Skurnik M, Granfors K, Mottonen T, Saano R, Toivanen A, Toivanen P (1990) A tetrapeptide shared by Yersinia outer membrane protein Yop 1 and HLA-B27; immune response in patients with Yersinia-triggered reactive arthritis. Scand J Rhematol Suppl 87: 70-71
34. Lahesmaa R, Skurnik M, Vaara M, Leirisalo-Repo M, Nisssila M, Granfors K (1991) Molecular mimickry between HLA-B27 and Yersinia, Salmonella, Shigeila and Klebsiella within the same region of HLA-α1-helix. Clin Exp Immunol 86: 399-404
35. Lahesmaa R, Skurnik M, Granfors K, Mottonen T, Saano R, Toivanen A, Toivanen P (1992) Molecular mimicry in the pathogenesis of spondyloarthropathies. A critical appraisal of cross reactivity between microbial antigens and HLA-B27. Br J Rheumatol 31. 221-229
36. Lahesmaa-Rantala R, Granfors K, Isomaki H, Toivanen A (1987) Yersinia-specific immune complexes in synovial fluid of patients with Yersinia-triggered reactive arthritis. Ann Rheum Dis 46: 510-514
37. Maclean L (1992) HLA-B27 subtypes: implications for the spondyloarthropathies Ann Rheum Dis 51: 929-931
38. Madden DR, Gorga JC, Strominger JL, Wiley DC (1991) The structure of HLA-B27 reveals nonamer self peptide bound in an extended conformation. Nature 353: 321-325
39. Madden DR, Gorga JC, Strominger JL, Wiley DC (1992) The three-dimensional structure of HLA-827 at 2.1 A° resolution suggests a general mechanism for tight binding to MHC. Cell 70: 1035-1048
40. Maki-Ikola O, Granfors K (1992) Salmonella-triggered reactive arthritis. Lancet 339. 1096-1097
41. Maki-Ikola O, Lehtinen K, Granfors K, Vanionpaa R, Toivanen P (1991) Bacterial antibodies in ankylosing spondylitis Clin Exp Immunol 84: 472-475
42. Maksymowyck WP, Wessler A, Schmitt-Egenolf M, Suarez-Almozer M, Ritzel G, Borstel RCV, Pazderka F, Russel AS (1994) Polymorphism in an HLA linked proteosome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol 21 665-669
43. Merilahti-Palo R, Soderstorm K-O, Lehesmma-Rantala R, Granfors K, Toivanen A (1991) Yersinia enterocolitica in the synovial membrane in Yersinia-triggered reactive arthritis. Ann Rheum Dis 50: 81-90
44. Merilahti-Palo R, Gripenberg-Lerche C, Soderstorm K-O, Toivanen P (1992) Long term follow up of SHR rats of experimental yersinia associated arthritis. Ann Rheum Dis 51: 91-96
45. Mertz AKH, Batford SR, Curschellas E, Kist MJ, Gondolf KB (1991) Cationic Yersinia antigen-induced chronic allergic arthritis in rats: A model for reactive arthritis in humans J Clin Invest 87: 632-642
46. Nickerson CL, Luthra HS, Savarirayan S, David CS (1990a) Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infection Hum Immunol 28: 382-396
47. Nickerson CL, Hanson J, David CS (1990b) Expression of HLA-B27 in transgenic mice is dependent on the mouse class I H2-D genes J Exp Med 172. 1255-1261
48. Nickerson CL, Hogen KL, Luthra HS, David CS (1990c) Effect of H-2 genes on expression on HLA-B27 and Yersinia-induced arthritis. Scand J Rheumatol Suppl 87: 85-90
49. Ogasawara M, Kono DH, Yu DTY (1986) Mimicry of human histocompatibility HLA-B27 antigens by Klebsiella pneumoniae. Infect Immun 51: 901-908
50. Parham P, Lomen CE, Lawlor DA, Ways JP, Holmes N, Coppin HL, Salter RD, Wan A-M, Ennis PD (1988) Nature of the polymorphism in HLA-A, -B and -C molecules. Proc Natl Acad Sci USA 85: 4005-4009
51. Pazmany L, Rowland-Jones S, Huet S, Hill A, Sutton J, Murrey R, Brooks J, McMichael A (1992) Genetic modulation of antigen presentation by HLA-B27 molecules. J Exp Med 175: 361-369
52. Pedrinaci S, Hanson J, David C (1994) Hierarchy in the assembly of HLA-B27 and HLA-Cw3 molecules in transgenic mice. Immunogenetics 39: 130-137
53. Powis SH, Tonks S, Mockridge I, Kelly AP, Bodmer JG, Trowsdale J (1993) Alteles and haplotype of the MHC-encoded ABC transporters Tap1 and Tap2 Immunogenetics 37: 373-380
54. Raybourne RB, Bunning VK, Williams KN (1988) Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigelia species: evidence for molecular mimicry in the spondyloarthropathtes J Immunol 140: 3489-3495
55. Reboul M, Frangoulis B, Rocca A, Degos L, Pla M (1991) Recognition of HLA-B27 by mouse cytotoxic T-cell clones, a transgenic mouse model. Immunogenetics 34: 196-200
56. Rojo S, Garcia F, Villadangos JA, Lopez de Castro JA (1993) Changes in the repertoire of peptide bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket BJ Exp Med 177. 613-620
57. Roudier J, De Montclos H, Thouvenot D, Chomel JJ, Guillermet FN, Betuel H (1985) Absence of cross reaction between HLA-B27 and Yersinia enterocolitica and Chlamydia tracheomatis in reactive arthritis and ankylosing spondytitis. Clin Rheumatol 4: 487
58. Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human htstocompatibility antigen HLA-A2 at 2 6 A° resolution J Mol Biol 219: 277-319
59. Savarirayan S, Prakash S, Banarjee S, Haqqi T, Little R, Hanson J, McCormick J, Nickerson CL, David CS (1988) Expression of HLA-B27 in association with mouse β2-microglobulin in transgenic mice. Fed Proc 2: A889
60. Schwimmbeck PL, Yu DT, Oldstone MB (1987) Autoantibodses to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter's syndrome Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 166: 173-181
61. Singh B, Milton JD, Woodrow JC (1986) Ankylosing spondylitts, HLA-B27 and Klebsiella. a study of lymphocyte reactivity of anti-klebsiella sera. Ann Rheum Dis 45: 190-197
62. Singh B, Dillion T, Lauzon J, Fraza E, Russell AS (1994) Tolerance to the HLA-B27 and Klebsiella pneumoniae cross reactive epitope in mice transgenic for HLA-B2705 and human β2-microglobulin. J Rheumatol 21: 670-674
63. Shodjai-Moradi F, Ebringer A, Abul Jadayel I (1992) IgA antibody response to Klebsiella in ankylosing spondylitis measured by immunoblotting. Ann Rheum Dis 51: 233-237
64. Tanigaki N, Fruci D, Vigneti E, Strace G, Rovero P, Londei M, Butler RH, Tosi R (1994) The peptide binding specificity of HLA-B27 subtype Immunogenetics 40: 192-198
65. Taurog JD, Lowen L, Forman J, Hammer RE (1988) HLA-B27 in inbred and noninbred transgenic mice: cell surface expression and recognition as an alloantigen in the absence of human β2-microglobulin. J Immunol 141. 4020-4023
66. Taurog LD, Maika SD, Simmons WA, Breban M, Hammer RE (1993) Susceptibility to inflammatory disease in HL-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 150: 4168-4178
67. Tsuchiya N, Husby G, Williams RC Jr (1989) Studies of humoral and cell-mediated immunity to peptide shared by HLA-B27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clin Exp Immunol 76 354-360
68. Ulker N, Lewis KD, Hood LE, Stroynowski I (1990) Activated T cells transcribe an alternatively spliced mRNA encoding a soluble form of Oa-2 antigen EMBO J 9: 3839-3847
69. Urban RG, Chicz RM, Lane WS, Strominger JL, Rehm A, Kenter MJH, UytdeHaag FGCM, Plough H, Uchanska-Ziegler B, Ziegler A (1994) A subset of HLA-B27 molecules contains peptide much longer that nonamers. Proc Natl Acad Sci USA 91 1534-1538
70. Van Bohemen CG, Grumet FC, Zanen HC (1984) Identification of HLA-B27M1 and M2 cross reactive antigens in Klebsiella. Shigella and Yersinia Immunology 52. 607-610
71. Van Endert PM, Lopez MR, Patel SD, Monaco JJ, McDevitt HO (1992) Genomic polymorphism, recombination and linkage disequilibrium in human major histocompatibility complex-encoded antigen processing genes. Proc Natl Acad Sci USA 89. 11594-11597
72. Viner NJ, Bailey LC, Life PF, Bacon PA, Gaston JSH (1991) Isolation of Yersinia-specific T-cell clones from the synovial membrane and synovial fluid of a patients with reactive arthritis. Arthritis Rheum 34: 1151-1157
73. Wang J, Yu DTU, Fukazawa T, Kellner H, Wen J, Cheng X-K, Roth G, Williams KM, Raybourne RB (1994) A monoclonal antibody that recognizes HLA-B27 in context of peptides J Immunol 152: 1197-1205
74. Weiss EH, Schliesser H, Rietmullar G, Kievits F, Ivanyi P, Brem G (1990a) The copy number and the presence of human beta 2 microglobulin control cell surface expression of HLA-B27 antigen transgenic mice with a 25 kb B27 gene fragment. In: Egorov I, David CS (eds) Transgenic mice and mutants in MHC research. Springer, Berlin Heidelberg New York, pp 205-213
75. Weiss EH, Schliesser G, Botteron C, McMichael A, Riethmuller G, Kievits F, Ivanyi P, Brem G (1990b) HLA class I transgenic mice as model system to study MHC-restricted antigen recognition in man Scand J Rheumatol Suppl 87: 91-96
76. Wen J, Wang J, Kuipers JG, Guang F, Williams KM, Raybourne RB, Yu DTU (1994) Analysis of HLA-B*2505 peptide motif, using T2 cells and monoclonal antibody ME1 Immunogenetics 39: 444-446
77. Zhou P, Cao H, Smart M, David C (1993) Molecular basis of genetic polymorphism in major histocompatibility complex-linked proteosome gene (Lmp-2). Proc Natl Acad Sci USA 90. 2681-2684